813 related articles for article (PubMed ID: 25638496)
1. GPCR crystal structures: Medicinal chemistry in the pocket.
Shonberg J; Kling RC; Gmeiner P; Löber S
Bioorg Med Chem; 2015 Jul; 23(14):3880-906. PubMed ID: 25638496
[TBL] [Abstract][Full Text] [Related]
2. Structural insights into ligand recognition and selectivity for classes A, B, and C GPCRs.
Lee SM; Booe JM; Pioszak AA
Eur J Pharmacol; 2015 Sep; 763(Pt B):196-205. PubMed ID: 25981303
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for ligand binding and specificity in adrenergic receptors: implications for GPCR-targeted drug discovery.
Huber T; Menon S; Sakmar TP
Biochemistry; 2008 Oct; 47(42):11013-23. PubMed ID: 18821775
[TBL] [Abstract][Full Text] [Related]
4. Improving virtual screening of G protein-coupled receptors via ligand-directed modeling.
Coudrat T; Simms J; Christopoulos A; Wootten D; Sexton PM
PLoS Comput Biol; 2017 Nov; 13(11):e1005819. PubMed ID: 29131821
[TBL] [Abstract][Full Text] [Related]
5. Efficiency of Homology Modeling Assisted Molecular Docking in G-protein Coupled Receptors.
Bhunia SS; Saxena AK
Curr Top Med Chem; 2021; 21(4):269-294. PubMed ID: 32901584
[TBL] [Abstract][Full Text] [Related]
6. Biased agonism at G protein-coupled receptors: the promise and the challenges--a medicinal chemistry perspective.
Shonberg J; Lopez L; Scammells PJ; Christopoulos A; Capuano B; Lane JR
Med Res Rev; 2014 Nov; 34(6):1286-330. PubMed ID: 24796277
[TBL] [Abstract][Full Text] [Related]
7. G protein-coupled receptor transmembrane binding pockets and their applications in GPCR research and drug discovery: a survey.
Kratochwil NA; Gatti-McArthur S; Hoener MC; Lindemann L; Christ AD; Green LG; Guba W; Martin RE; Malherbe P; Porter RH; Slack JP; Winnig M; Dehmlow H; Grether U; Hertel C; Narquizian R; Panousis CG; Kolczewski S; Steward L
Curr Top Med Chem; 2011; 11(15):1902-24. PubMed ID: 21470172
[TBL] [Abstract][Full Text] [Related]
8. X-ray structure breakthroughs in the GPCR transmembrane region.
Topiol S; Sabio M
Biochem Pharmacol; 2009 Jul; 78(1):11-20. PubMed ID: 19447219
[TBL] [Abstract][Full Text] [Related]
9. Small Molecule Allosteric Modulators of G-Protein-Coupled Receptors: Drug-Target Interactions.
Lu S; Zhang J
J Med Chem; 2019 Jan; 62(1):24-45. PubMed ID: 29457894
[TBL] [Abstract][Full Text] [Related]
10. GPCR structures in drug design, emerging opportunities with new structures.
Tautermann CS
Bioorg Med Chem Lett; 2014 Sep; 24(17):4073-9. PubMed ID: 25086683
[TBL] [Abstract][Full Text] [Related]
11. Recent Advances in Structure-Based Drug Design Targeting Class A G Protein-Coupled Receptors Utilizing Crystal Structures and Computational Simulations.
Lee Y; Basith S; Choi S
J Med Chem; 2018 Jan; 61(1):1-46. PubMed ID: 28657745
[TBL] [Abstract][Full Text] [Related]
12. GPCR activation: a mutagenic spotlight on crystal structures.
Hulme EC
Trends Pharmacol Sci; 2013 Jan; 34(1):67-84. PubMed ID: 23245528
[TBL] [Abstract][Full Text] [Related]
13. Structure-Based Prediction of G-Protein-Coupled Receptor Ligand Function: A β-Adrenoceptor Case Study.
Kooistra AJ; Leurs R; de Esch IJ; de Graaf C
J Chem Inf Model; 2015 May; 55(5):1045-61. PubMed ID: 25848966
[TBL] [Abstract][Full Text] [Related]
14. Current and Future Challenges in GPCR Drug Discovery.
Topiol S
Methods Mol Biol; 2018; 1705():1-21. PubMed ID: 29188556
[TBL] [Abstract][Full Text] [Related]
15. Structure of β-adrenergic receptors.
Brueckner F; Piscitelli CL; Tsai CJ; Standfuss J; Deupi X; Schertler GF
Methods Enzymol; 2013; 520():117-51. PubMed ID: 23332698
[TBL] [Abstract][Full Text] [Related]
16. Structures of G protein-coupled receptors reveal new opportunities for drug discovery.
Cooke RM; Brown AJ; Marshall FH; Mason JS
Drug Discov Today; 2015 Nov; 20(11):1355-64. PubMed ID: 26303408
[TBL] [Abstract][Full Text] [Related]
17. Chemical Diversity in the G Protein-Coupled Receptor Superfamily.
Vass M; Kooistra AJ; Yang D; Stevens RC; Wang MW; de Graaf C
Trends Pharmacol Sci; 2018 May; 39(5):494-512. PubMed ID: 29576399
[TBL] [Abstract][Full Text] [Related]
18. Class A GPCRs: Structure, Function, Modeling and Structure-based Ligand Design.
Cong X; Topin J; Golebiowski J
Curr Pharm Des; 2017 Nov; 23(29):4390-4409. PubMed ID: 28699533
[TBL] [Abstract][Full Text] [Related]
19. Allosteric ligands for G protein-coupled receptors: a novel strategy with attractive therapeutic opportunities.
De Amici M; Dallanoce C; Holzgrabe U; Tränkle C; Mohr K
Med Res Rev; 2010 May; 30(3):463-549. PubMed ID: 19557759
[TBL] [Abstract][Full Text] [Related]
20. Orthosteric/allosteric bitopic ligands: going hybrid at GPCRs.
Valant C; Sexton PM; Christopoulos A
Mol Interv; 2009 Jun; 9(3):125-35. PubMed ID: 19592673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
